Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-24

FDA Approved: GABAPENTIN — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approves Rising Pharma's original application for gabapentin, a generic version of the anticonvulsant, for the treatment of epilepsy (partial seizures) and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

ORIG AP for GABAPENTIN (GABAPENTIN)